The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
![]() ![]() | Sohier, J. (2013). Sélection et caractérisation de Nanobodies inhibiteurs de métallo-β-lactamases [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/156642 |
![]() ![]() | Sohier, J., Laurent, C., Chevigné, A., Pardon, E., Srinivasan, V., Wernery, U., Lassaux, P., Steyaert, J., & Galleni, M. (15 March 2013). Allosteric inhibition of VIM metallo-beta-lactamase by a camelid nanobody. Biochemical Journal, 450 (3), 477-486. doi:10.1042/BJ20121305 ![]() |
![]() ![]() | Sohier, J. (28 September 2012). Le retour de la phagothérapie. Et pourquoi pas… [Paper presentation]. Séminaire de thèse présenté dans le cadre des séminaires du Centre d'Ingénierie des Protéines. |
![]() ![]() | Sohier, J., Laurent, C., Chevigné, A., Pardon, E., Srinivasan, V., Lassaux, P., Buys, N., Willibal, K., Steyaert, J., & Galleni, M. (2012). Allosteric inhibition of VIMs metallo-β-lactamases by a camelid single-domain antibody fragment [Poster presentation]. Biomedica 2012. |
![]() ![]() | Laurent, C., Sohier, J., Pardon, E., Lassaux, P., Buys, N., Willibal, K., Steyaert, J., Wyns, L., & Galleni, M. (10 December 2011). Characterization of the inhibition of metallo-β-lactamases of subclass B1 by VHHs cAbVIM4 and cAbBCII10 [Poster presentation]. journée doctorale SFMBBM, Liège, Belgium. |
![]() ![]() | Lassaux, P., Traoré, D., Loisel, E., Favier, A., Docquier, J.-D., Sohier, J., Laurent, C., Bebrone, C., Frère, J.-M., Ferrer, J.-L., & Galleni, M. (2011). Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01486-09 ![]() |
![]() ![]() | Bebrone, C., Lassaux, P., Vercheval, L., Sohier, J., Jehaes, A., Sauvage, E., & Galleni, M. (16 April 2010). Current challenges in antimicrobial chemotherapy: focus on beta-lactamase inhibition. Drugs, 70(6), 651-679. doi:10.2165/11318430-000000000-00000 ![]() |
Sohier, J., Laurent, C., Pardon, E., Lassaux, P., Buys, N., Willibal, K., Steyaert, J., Wyns, L., & Galleni, M. (2010). cAbVIM4, a nanobody inhibiting the metallo-β-lactamase VIM-4 [Poster presentation]. 35th FEBS Congress: Molecules of Life, Göteborg, Sweden. |
![]() ![]() | Sohier, J., Laurent, C., Chevigné, A., Pardon, E., Srinvasan, V., Lassaux, P., Buys, N., Willibal, K., Steyaert, J., & Galleni, M. (2010). Characterisation of B1 metallo-beta-lactamase inhibition by VHHs. |
Sohier, J., Laurent, C., Pardon, E., Srinivasan, V., Lassaux, P., Buys, N., Willibal, K., Steyaert, J., & Galleni, M. (2010). CA1838, A NANOBODY INHIBITING THE METALLO-β-LACTAMASE VIM-4 [Poster presentation]. Single Domain Antibodies Come of Age. |
![]() ![]() | D'Amico, S., Sohier, J., & Feller, G. (May 2006). Kinetics and energetics of ligand binding determined by microcalorimetry: Insights into active site mobility in a psychrophilic alpha-amylase. Journal of Molecular Biology, 358 (5), 1296-1304. doi:10.1016/j.jmb.2006.03.004 ![]() |